Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design Source: ERJ Open Res, 5 (4) 00061-2019; 10.1183/23120541.00061-2019 Year: 2019
A smart mHealth tool versus a paper action plan to support self-management of COPD exacerbations: a randomised controlled trial Source: International Congress 2019 – M-health/e-health I Year: 2019
A novel study design for the comparison between once-daily QVA149 and twice-daily salmeterol/fluticasone on the reduction of COPD exacerbations: The FLAME study Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013
Design and implementation of a multi-part, flexible protocol to assess the tolerability and pharmacodynamic effects of PUR118 in healthy subjects and COPD patients Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
COPD and Seretide: a multi-centre intervention and characterisation (COSMIC) study: rationale and baseline characteristics Source: Eur Respir J 2002; 20: Suppl. 38, 241s Year: 2002
An electronic patient decision aid comparing as-needed budesonide-formoterol combination to regular use of inhaled corticosteroid (ICS) in mild asthma: a rapid-cycle design study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021
Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017 Year: 2018
Efficacy of a comprehensive education program including inhaler training and COPD management during hospitalization of AECOPD, a randomized controlled clinical Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018
Effectiveness and acceptability of a smart inhaler asthma self-management programme: a cluster RCT study protocol Source: International Congress 2019 – Innovations in primary care assessment and management Year: 2019
Budesonide/formoterol adjustable maintenance dosing effectively improves asthma symptom severity: a multicentre Canadian study Source: Eur Respir J 2003; 22: Suppl. 45, 258s Year: 2003
Evaluation of data requirements to establish biologic quality control ranges in a multi-center clinical trial for inhaled insulin Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future Year: 2008
Initial inhaler choice in COPD: real-world evidence Source: Breathe, 15 (4) 350; 10.1183/20734735.0256-2019 Year: 2019
Efficacy and safety of sequential three-step empirical therapy for chronic cough: a multi-center clinical study Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Effects of an internet based tool for self-management in patients with COPD–a controlled pragmatic pilot trial Source: International Congress 2017 – The importance of physical activity in patients with COPD Year: 2017
Safety profile of glycopyrronium in patients with COPD: An innovative approach to analyse data from post-marketing surveillance (PMS) Source: International Congress 2014 – Asthma and COPD management Year: 2014
Comparison of an innovative multi-dose inhaler with the attributes of an 'ideal' inhaler: A multicentre randomised controlled trial (RCT) Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response Source: Eur Respir Rev 2014; 23: 367-378 Year: 2014
The cost-effectiveness of early intervention with inhaled budesonide once daily: an international comparison of the results from the START study Source: Eur Respir J 2002; 20: Suppl. 38, 43s Year: 2002
Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018